Key result
Radical surgery for primary retroperitoneal sarcomas yields ~48% five-year survival.
Why the study?
The impact of aggressive surgical treatment on long-term survival in patients with primary retroperitoneal sarcomas was evaluated due to limited outcome data.
Does aggressive surgical treatment improve survival in patients with primary retroperitoneal soft tissue sarcomas?
Cohort (n=42)
No
Does aggressive surgical treatment improve survival in patients with primary retroperitoneal soft tissue sarcomas?
Wide surgical excision offers a concrete chance for long-term survival in patients with primary retroperitoneal sarcomas, though tumor classification and stage remain significant prognostic factors.
Answers are grounded in this paper and cite their sources.
Supports radical resection for potential long-term survival in retroperitoneal sarcomas; leaves open comparative effectiveness and adjuvant strategies.
A retrospective study was undertaken to evaluate the results of surgical treatment in a series of patients with primary retroperitoneal sarcomas consecutively treated by the same surgical team. The hospital records of 42 patients with primary retroperitoneal sarcomas who underwent surgical exploration at our unit from 1984 to 1995 were reviewed. A univariate analysis was used to identify the main clinical, pathologic, and treatment-related factors affecting long-term survival. Twenty-five patients (59.6%) underwent radical surgery. The 5-year survival and 5-year disease-free survival after radical resection were 48.1% and 38.8%, respectively. According to the univariate analysis of survival tumor classification (T), stage and gross surgical margins significantly affected prognosis. The study indicates that even though there are predetermined and unmodifiable tumor-related factors, such as tumor classification (T) and stage, that influence survival in patients with retroperitoneal sarcomas, wide surgical excision offers a concrete chance for long-term survival.
No takes yet. Share an insight, caveat, or question.
Malerba et al. (1999) conducted a cohort in Primary retroperitoneal sarcomas (n=42). Radical surgery was evaluated on 5-year survival. Radical surgery for primary retroperitoneal sarcomas resulted in a 5-year survival of 48.1% and a 5-year disease-free survival of 38.8%.
Synapse has enriched 10 related papers. Consider them for comparative context: